Development of Artificial Intelligence-Based Approaches for Computer-Aided Management of Colorectal Polyps
Development of Artificial Intelligence-Based Approaches for Computer-Aided Management of Colorectal Polyps
批准号:
10479308
负责人:
Eladio Rodriguez-Diaz
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-10-01 至 2026-09-30
关键词:
AdoptionAgeAmericanArtificial IntelligenceAspirinAugmented RealityBenignBiological MarkersBiopsyBody mass indexCancer EtiologyCessation of lifeClassificationClinicalClinical DataColonColonic NeoplasmsColonoscopyColorectal CancerColorectal NeoplasmsColorectal PolypComputer AssistedComputer-Assisted DiagnosisComputersCost SavingsDataData SetDatabasesDetectionDevelopmentDiagnosisDisease OutcomeDiverticulumDocumentationEducational process of instructingElectronic Health RecordEndoscopesEndoscopyExcisionExplosionFamily history ofFriendsGastrointestinal EndoscopyGenderGenerationsGoalsGuidelinesHealthcareImageImage AnalysisIndividualInterobserver VariabilityInterventionIntestinesIntuitionLabelLaboratory StudyLightMeasuresMethodsModelingMorbidity - disease rateMucous MembraneNeoplastic PolypOpticsOutputPathologyPatientsPerformancePolypectomyPolypsPrecancerous PolypPreparationProceduresRecordsRectumReportingResearchResectedRestRiskRisk FactorsScreening for cancerSemanticsSerrated AdenomaSocietiesTattooingTechnologyTestingTimeTissuesUnited StatesVisualizationcancer riskcare burdenclinical practiceclinical riskclinically relevantcolon cancer preventioncolorectal cancer riskcolorectal cancer screeningcostcost effectivenessdeep field surveydeep learningdeep learning modeldesignexperienceimprovedinnovationmodel designmortalitynetwork architecturepatient screeningpolyposispredictive modelingpreservationquantitative imagingrectalskillsvisual feedback
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background and Objectives: Colorectal cancer (CRC) is the second leading cause of cancer death in the
United States, with nearly 150,000 new cases and 50,000 deaths annually. Colonoscopy with polypectomy
remains the gold standard for CRC screening and surveillance since removal of neoplastic polyps during
colonoscopy modifies disease outcomes and informs subsequent management. Standard practice
continues to favor removal of all visualized polyps for histopathological assessment, despite estimates that
nearly half of the polyps are non-neoplastic. Studies have shown that the capability to reliably predict polyp
pathology endoscopically in real time could result in substantial improvement in the cost-effectiveness of
colonoscopy for CRC. The number of colonoscopies performed is increasing, and in the VA more than
doubled in a five-year span. This demand does not include subsequent procedures required in ~30% of
screened patients. Thus, colonoscopy can benefit greatly from efficiency improvements at every level. In
light of this, the past decade has seen an explosion in advances in endoscopic technologies toward
diagnosing and treating colorectal neoplasia more precisely. Recent advances in artificial intelligence (AI),
specifically in the field of deep learning, and their application to endoscopic imaging, have shown promise
for automating endoscopic polyp pathology predictions, overcoming operator-based polyp pathology
assessment factors such as interobserver variability, skill, and experience. Such capability would finally
open the door to widespread adoption of cost-saving resect-and-discard and leave-behind paradigms for
diminutive polyps, as proposed by the American Society for Gastrointestinal Endoscopy Preservation and
Incorporation of Valuable Endoscopic Innovations guidelines. More importantly, the incorporation of AI-
based quantitative image interpretation into clinical practice, including in the VA, has the potential to
increase early cancer detection thus reducing patient morbidity and mortality. To this end, the main goal
of the proposed study is to leverage AI, specifically deep learning models, to develop an accurate and
robust computer aided diagnosis (CADx) platform to enable the purely endoscopic, optical assessment of
mucosal pathologies, specifically colorectal polyps. In parallel, the use of AI models to assess colonic
mucosal and luminal features known to inform colonoscopy quality will be investigated.
Methods: The study will be guided by three aims. In Aim 1 robust classification models for predicting polyp
pathology will be developed. Labeled images and clinical data, from existing datasets and clinical records,
will be used to design and validate deep learning models. The design will consist of two steps: outlining
regions in an image containing a polyp, and subsequent analysis of the polyp region to provide a pathology
prediction. Borrowing from aspects of augmented reality, the pathology prediction along with the estimated
polyp boundary, will be presented to endoscopists in an intuitive and clinically friendly manner as a pseudo-
color overlay, enhancing the transparency and interpretability of the models output predictions. This
immediate visual feedback can thus inform clinical decisions during colonoscopy. Aim 2 will focus on using
clinical risk factors associated with colorectal neoplasia in combination with endoscopic imaging data to
enhance predictions of polyp pathology. The goal is to investigate incorporation of recognized CRC clinical
risk factors and biomarkers, obtained from patients’ electronic health records, in our polyp pathology
prediction deep learning models. Finally, in Aim 3 the deep learning-based detection, segmentation, and
classification frameworks developed in Aim 1 will be adapted for scoring bowel preparation, recognizing
cecal landmarks and rectal retroflexion, identifying colonic diverticula, and delineating endoscopic tattoo
markings. These features are associated with performing of high-quality colonoscopy, for which automated
identification could improve and facilitate documentation of endoscopic findings and report generation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: